Tag: Caladrius Biosciences

December 2, 2019

Top 10 Stem Cell Companies On The NASDAQ

The global stem cell therapy market is expected to grow at a CAGR of 36.52 percent between 2017 and 2021....
September 23, 2018

5 Top Weekly NASDAQ Biotech Stocks: Molecular Templates on Top

Molecular Templates, Galectin Therapeutic, Chiasma, ZioPharm Oncology and Caladrius Biosciences were last week's top gainers on the NASDAQ Biotechnology Index.
September 17, 2018

Investing in Glucose Monitoring Devices

Diabetes is one of the 10 top killers around the world, and as the healthcare industry races to accommodate growing demand...
July 4, 2018

5 Top NASDAQ Pharma Stocks of Q2 2018

About half way through 2018 finishing the second quarter, the INN takes a look at the 5 top pharma stocks...
March 23, 2018

Caladrius Biosciences Reports 2017 Fourth Quarter and Year End Financial Results

Caladrius Biosciences (Nasdaq:CLBS) a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and select cardiovascular indications, announces financial results...
January 18, 2018

Caladrius Biosciences Announces Completion of Enrollment of Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes

Caladrius Biosciences (NASDAQ:CLBS) a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and select cardiology indications, announces the completion of...